dario.olivero – Pagina 40 – AMD

dario.olivero

Settembre 5, 2023 dario.olivero

Bringing precision medicine to the management of pregnancy in women with glucokinase-MODY: a study of diagnostic accuracy and feasibility of non-invasive prenatal testing

Hughes AE, Houghton JAL, Bunce B, et al.
Diabetologia. Pub. online 31 Aug 2023.

Leggi

Settembre 5, 2023 dario.olivero

Trajectories of fasting glucose and glycated haemoglobin in obese and non-obese incident diabetes: Results from two large cohort studies

Yu HJ, Ho M, Chau PH, Fong DYT
Diabetes Obes Metab. 2023;25(10):2835-2845.

Leggi

Settembre 1, 2023 dario.olivero

Metabolomic insights into maternal and neonatal complications in pregnancies affected by type 1 diabetes

Meek CL, Stewart ZA, Feig DS, et al.
Diabetologia. Pub. online 24 Aug 2023.

Leggi

Settembre 1, 2023 dario.olivero

Exploring the gut microbiota in patients with pre-diabetes and treatment naïve diabetes type 2 – a pilot study

Gravda K, Kirste KH, Grzelak K, et al.
BMC Endocr Disord. 2023;23(1):179.

Leggi

Settembre 1, 2023 dario.olivero

Dapagliflozin in patients with heart failure and deterioration in estimate glomerular filtration rate to <25ml/min/1.73m2

Chatur S, Vaduganathan M, Claggett BL, et al.
J Am Coll Cardiol. 2023;S0735-1097(23)06532-4.

Leggi

Settembre 1, 2023 dario.olivero

Efficacy of dapagliflozin according to geographic location of patients with heart failure

Kondo T, Wang X, Yang M, et al.
J Am Coll Cardiol. 2023;82(10):1014–1026.

Leggi

Agosto 28, 2023 dario.olivero

2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC)

Marx N, Federici M, Schütt K, et al.
European Heart Journal. Pub. online 25 Aug 2023.

Leggi

Agosto 4, 2023 dario.olivero

Glycaemic control, risk of hypoglycaemia and all-cause mortality in new users of second-generation basal insulin with type 2 diabetes and chronic kidney disease: a nationwide register-based cohort study

Kosjerina V, Carstensen B, Amadid H, Vistisen D
Diabetologia. Pub. online 28 Jul 2023.

Leggi

Agosto 4, 2023 dario.olivero

Clinical outcomes associated with drugs for obesity and overweight: A systematic review and network meta‐analysis of randomized controlled trials

Iannone A, Natale P, Palmer SC, et al.
Diabetes Obes Metab. 2023;25(9):2535-2544.

Leggi

Agosto 4, 2023 dario.olivero

Associations of lipoprotein subclasses with risk of all‐cause and cardiovascular disease mortality in individuals with type 2 diabetes: A prospective cohort study

Li R, Chen JX, Lu Q, et al.
Diabetes Obes Metab. Pub. online 26 Jul 2023.

Leggi